Skip to main navigation
Logo

Investors

Press Releases

Press Releases

  • All
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2016
January 22, 2024
Adicet Bio, Inc. Announces Pricing of Public Offering
January 22, 2024
Adicet Bio, Inc. Announces Proposed Public Offering
January 4, 2024
Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
January 3, 2024
Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook
December 29, 2023
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
December 10, 2023
Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting
November 8, 2023
Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates
November 7, 2023
Adicet Bio to Present at the 2023 Jefferies London Healthcare Conference
November 2, 2023
Adicet Bio Announces Poster Presentation Highlighting ADI-001 Data at the 65th American Society of Hematology (ASH) Annual Meeting
October 31, 2023
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »
Displaying 41 - 50 of 163

Tools

  • Print
    Print
  • Email Alerts
    Email Alerts
  • Investor Contacts
    Investor Contacts

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Investor Resources

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
    • Stock Quote & Chart
    • Analyst Coverage
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts

Adicet - Header Navigation

  • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Gamma Delta T Cells
    • Targeting Moieties
    • Proprietary Cell Platform
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Presentations and Publications
  • Investors
    • Overview
    • Press Releases
    • Presentations & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • Investor Resources
  • Careers
    • Join Our Team
    • Current Openings
  • Contact

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
  • Investor Resources
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts
Logo © 2024 Adicet Bio All rights reserved. Website Design: Hane Chow, Inc.